Table III.
Vascularity findings of malignant and benign breast lesions using CDFI and SMI, [n (%)].
| CDFI | SMI | |||||
|---|---|---|---|---|---|---|
| Variable | Malignant (n=30) | Benign (n=86) | P-value | Malignant (n=30) | Benign (n=86) | P-value |
| Adler classification | 0.009 | <0.001a | ||||
| Grade 0 | 2 (6.7) | 19 (22.1) | 1 (3.3) | 16 (18.6) | ||
| Grade 1 | 5 (16.7) | 25 (29.1) | 2 (6.7) | 14 (16.3) | ||
| Grade 2 | 6 (20.0) | 21 (24.4) | 3 (10.0) | 31 (36.0) | ||
| Grade 3 | 17 (56.7) | 21 (24.4) | 24 (80.0) | 25 (29.1) | ||
| Morphology | <0.001 | <0.001a | ||||
| N/A | 2 (6.7) | 19 (22.1) | 1 (3.3) | 16 (18.6) | ||
| Linear | 14 (46.7) | 44 (51.2) | 1 (3.3) | 49 (57.0) | ||
| Dot-like | 7 (23.3) | 23 (26.7) | 2 (6.7) | 17 (19.8) | ||
| Penetrating | 2 (6.7) | 0 (0.0) | 2 (6.7) | 2 (2.3) | ||
| Branching | 2 (6.7) | 0 (0.0) | 1 (3.3) | 2 (2.3) | ||
| Penetrating & Branching | 3 (10.0) | 0 (0.0) | 16 (53.3) | 0 (0.0) | ||
| Penetrating & Branching & Shunt | 0 (0.0) | 0 (0.0) | 7 (23.3) | 0 (0.0) | ||
| Distribution | 0.269 | 0.220 | ||||
| N/A | 2 (6.7) | 19 (22.1) | 1 (3.3) | 16 (18.6) | ||
| Peripheral | 12 (40.0) | 33 (38.4) | 4 (13.3) | 10 (11.6) | ||
| Central | 3 (10.0) | 6 (7.0) | 5 (16.7) | 15 (17.4) | ||
| Both | 13 (43.3) | 28 (32.6) | 20 (66.7) | 45 (52.3) | ||
a
P<0.05.